UVA Protection Testing for Cosmetics: Standards, Methods, and Regulatory Compliance

UVA protection testing measures how effectively sunscreens and UV-protective cosmetics shield the skin from long-wave ultraviolet radiation (320–400 nm), the primary driver of photoaging, pigmentation, and long-term photodamage. Verified through standardized in vivo and in vitro methods such as ISO 24442 and ISO 24443, key metrics including UVA Protection Factor (UVAPF), persistent pigment darkening (PPD), and critical wavelength substantiate claims such as PA grading, the EU UVA logo, and broad-spectrum labeling. Accredited third-party laboratories perform these tests to support regulatory registration, global market access, and formulation development.

Technical Overview

Ultraviolet A (UVA) radiation covers the 320–400 nm wavelength band and accounts for approximately 95% of the ultraviolet energy reaching the Earth's surface. Unlike UVB (280–320 nm), which primarily causes sunburn, UVA penetrates deeply into the dermis, generates reactive oxygen species, degrades collagen and elastin, and induces both immediate and persistent pigment darkening. Chronic UVA exposure is strongly associated with photoaging, irregular pigmentation, melasma aggravation, and an elevated risk of skin cancer. Because UVA passes through window glass and remains significant year-round and under cloud cover, regulatory authorities worldwide require objective, laboratory-verified evidence before UVA protection claims may appear on cosmetic and sunscreen labels.

UVA protection testing quantifies product performance through several internationally recognized metrics. The UVA Protection Factor (UVAPF) expresses the ratio of UVA dose required to produce a defined biological or instrumental endpoint on protected versus unprotected skin. The critical wavelength identifies the wavelength below which 90% of the total UV absorbance of a product is achieved, with 370 nm serving as the accepted threshold for balanced broad-spectrum protection. In the European Union, Commission Recommendation 2006/647/EC requires that the UVAPF be at least one third of the labeled SPF and that the critical wavelength be at least 370 nm for use of the circular UVA logo. In the United States, the FDA final rule codified in 21 CFR Part 351 defines an in vitro broad-spectrum test based on the same 370 nm critical wavelength criterion. In Japan, China, and much of Asia, the PA system translates UVAPF (PPD) results into consumer-facing grades from PA+ to PA++++.

Testing Samples

Leave-On Sunscreen Products

Creams, lotions, milks, gels, oils, balms, and stick-format sunscreens constitute the core sample category. These products are tested in their finished, market-intended formulation, with packaging and any pump or airless delivery systems supplied where relevant to ensure the tested product matches the commercial form.

Sunscreen Sprays and Roll-Ons

Aerosol, pump-spray, and roll-on sunscreens require controlled sample collection and uniform substrate application. Specific application procedures are applied to confirm that the dispensed film delivers the labeled UVA protection when tested at the standard application rate.

Multi-Functional Skin Care with UV Claims

Day creams, moisturizers, essences, primers, and anti-aging products carrying SPF or UVA protection claims are tested to substantiate labeling. These products are evaluated under the same standardized conditions as dedicated sunscreens to ensure claim integrity.

Color Cosmetics with UV Protection Claims

Foundations, BB and CC creams, tinted moisturizers, and lip products with UV protection claims can be assessed, principally through in vitro spectrophotometric methods, since pigmented films on PMMA plates can be measured reproducibly using integrating-sphere instrumentation.

Water-Resistant and Sport Formulations

Products labeled water-resistant or very water-resistant undergo UVA water-resistance evaluation, in which UVAPF is re-measured after standardized immersion to verify that protection is retained under the claimed exposure conditions.

Typical submission requirements include a representative finished batch in its intended packaging, an adequate sample volume (indicatively 20–30 mL for in vitro studies and 50–100 mL for in vivo panel studies), formulation documentation, and any known photostability characteristics. Exact requirements are confirmed by the accredited third-party laboratory on a case-by-case basis.

Testing Items

• UVA Protection Factor (UVAPF) determination, in vivo per ISO 24442 or in vitro per ISO 24443
• Persistent pigment darkening (PPD) endpoint measurement on human subjects
• Critical wavelength (λc) determination across the 290–400 nm spectrum
• Broad-spectrum pass/fail classification in accordance with FDA requirements (21 CFR Part 351)
• EU UVA logo compliance verification against Commission Recommendation 2006/647/EC
• PA grade assignment from PA+ to PA++++ based on UVAPF thresholds
• Boots UVA star rating across five performance categories
• Photostability assessment based on absorbance change after pre-irradiation
• UVA water-resistance retention testing after standardized immersion

Testing Methods

In Vivo UVA Protection Factor — ISO 24442 (PPD Method)

The reference in vivo procedure applies the test product at 2 mg/cm² to defined areas on the backs of healthy adult volunteers with appropriate skin phototypes, following ethics approval and informed consent. A UVA solar simulator compliant with the required spectral output delivers graded doses to both protected and unprotected sites. The endpoint is persistent pigment darkening, a stable brownish pigmentation whose intensity is graded visually within the 2–24 hour stable window, typically several hours after exposure. The UVAPF is calculated as the ratio of the minimal UVA dose producing the PPD endpoint on protected skin to that on unprotected skin, with results from at least ten valid subjects required per the standard. This value directly supports PA grading and high-claim UVA labeling.

In Vitro UVA Protection Factor — ISO 24443 (Spectrophotometric Method)

The in vitro procedure spreads the product at 1.3 mg/cm² across roughened PMMA plates to mimic an uneven sunscreen film on skin. After a controlled conditioning period, the plates are pre-irradiated with a UVA dose scaled to the expected UVAPF to account for photo-induced changes in the formulation. UV transmittance is then scanned from 290 to 400 nm using a spectrophotometer equipped with an integrating sphere, and the UVAPF is computed from the absorbance curve weighted by the PPD action spectrum and a standard UVA source spectrum, calibrated against a validated reference formulation. The same absorbance data yield the critical wavelength, and measurements repeated after water immersion support in vitro UVA water-resistance determination.

Broad-Spectrum Testing — FDA Method (21 CFR Part 351)

Under the FDA sunscreen rule, an in vitro absorbance measurement across 290–400 nm is performed, and the critical wavelength is calculated. A product qualifies as broad spectrum when the critical wavelength equals or exceeds 370 nm, a prerequisite for protective claims linking sunscreen use to reduced risks of skin cancer and early skin aging when combined with SPF 15 or higher.

Critical Wavelength Determination

The critical wavelength is the wavelength at which the integral of the absorbance curve from 290 nm reaches 90% of the total area from 290 to 400 nm. Values of 370 nm or greater demonstrate that protection extends proportionally across the UVA range rather than being concentrated in the UVB region, and this parameter is accepted across EU, FDA, and ISO frameworks.

Boots UVA Star Rating

Widely used in the United Kingdom market, this rating compares mean UVA absorbance with mean UVB absorbance, including a pre-irradiation step in the current version to reflect photostability. The resulting ratio places the product into one of five categories, from one to five stars, with higher ratings indicating UVA protection closer in strength to the labeled SPF.

Photostability and Water-Resistance Assessment

Photostability is evaluated by comparing absorbance spectra before and after controlled UVA exposure, with significant loss of absorbance indicating degradation of UV filters during sun exposure. Water-resistance testing applies standardized immersion regimens, commonly successive 20-minute water exposures per European industry guidelines, followed by re-measurement of UVAPF to confirm the percentage of protection retained.

Applications

• Regulatory registration dossiers for the EU (under Regulation (EC) No 1223/2009 and Commission Recommendation 2006/647/EC), the United States OTC framework, China's special cosmetic registration system, and Japanese or ASEAN market entry
• Substantiation of label claims including the EU UVA logo, broad-spectrum statements, PA grades, and UVA star ratings
• Research and development support for comparing UV filter systems, optimizing formulations, and screening photostability before in vivo confirmation
• Quality control and batch-to-batch consistency verification, including post-stability testing on aged samples
• Market surveillance, import compliance checks, and independent verification of competitor or consumer-challenged claims

FAQ

What is the difference between SPF and UVA protection?

SPF measures protection against UVB-induced sunburn, while UVA protection metrics such as UVAPF and PPD measure defense against long-wave UVA radiation responsible for pigment darkening, photoaging, and deeper dermal damage. A high SPF alone does not guarantee adequate UVA defense, which is why separate UVA testing and balanced-protection criteria such as the one-third UVAPF-to-SPF ratio exist.

Why is 370 nm the threshold for critical wavelength?

A critical wavelength of 370 nm means 90% of the product's total UV absorbance is achieved only after extending into the UVA region beyond 370 nm, confirming proportional coverage across the full solar spectrum. This threshold has been harmonized across EU, FDA, and ISO frameworks as the criterion for balanced, broad-spectrum protection.

Should I choose the in vivo or in vitro UVA method?

In vivo ISO 24442 testing is generally required for definitive UVAPF values used in PA labeling and for high-stakes regulatory claims, while in vitro ISO 24443 testing is faster, lower in cost, and ideal for formulation screening, critical wavelength verification, and water-resistance assessment. Many development programs combine both, using in vitro screening followed by in vivo confirmation of the final formula.

How are PA grades assigned from test results?

Based on the measured UVAPF (PPD value), products are graded as PA+ for values of 2 to less than 4, PA++ for 4 to less than 8, PA+++ for 8 to less than 16, and PA++++ for 16 and above, following the grading convention established by the Japanese cosmetic industry association and adopted across many Asian markets.

How long does UVA protection testing take?

In vitro testing, including critical wavelength and photostability assessment, is typically completed within two to four weeks. In vivo studies require ethics review, panel recruitment, and sequential exposure and reading sessions, and generally require six to ten weeks depending on panel availability and the number of test products.

Why is pre-irradiation performed in in vitro testing?

Pre-irradiation exposes the product film to a controlled UVA dose before measurement to simulate initial sun exposure and reveal any photodegradation or photostabilizing behavior of the UV filter system. This step aligns laboratory results more closely with real-world performance and is an integral requirement of the ISO 24443 and star-rating protocols.